% | $
Quotes you view appear here for quick access.

Accuray Incorporated (ARAY) Message Board

  • fundahmental fundahmental Feb 14, 2013 8:19 AM Flag

    This could get juicy today

    CEO bought $437890 (reported last night after close) and he is presenting at a healthcare conference this morning at 9:20 am EST. Seems like a no brainer! Oh, plus there's about 10% short interest, so any news will make this turd float.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This is the best news to come along for this stock in awhile..good post

      • 1 Reply to greggjohn
      • FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
        Washington, D.C. 20549


        OMB Number: 3235-0287
        Estimated average burden
        hours per response... 0.5

        Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

        1. Name and Address of Reporting Person *

        LEVINE JOSHUA 2. Issuer Name and Ticker or Trading Symbol

        ACCURAY INC [ ARAY ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

        _____ Director _____ 10% Owner
        __ X __ Officer (give title below) _____ Other (specify below)
        President & CEO
        (Last) (First) (Middle)

        1310 CHESAPEAKE TERRACE 3. Date of Earliest Transaction (MM/DD/YYYY)


        SUNNYVALE, CA 94089
        (City) (State) (Zip) 4. If Amendment, Date Original Filed (MM/DD/YYYY)

        6. Individual or Joint/Group Filing (Check Applicable Line)

        _ X _ Form filed by One Reporting Person
        ___ Form filed by More than One Reporting Person

        Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
        1.Title of Security
        (Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
        (Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
        (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
        (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
        Code V Amount (A) or (D) Price
        Common Stock 2/13/2013 P 100000.0 A $4.3789 (1) 300000.0 D

        Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
        1. Title of Derivate Security
        (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
        (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
        (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
        (Instr. 3 and 4) 8. Price of Derivative Security
        (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
        Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

        Explanation of Responses:
        ( 1) The purchase price represents the weighted average purchase price of the shares purchased ranging from $4.3350 to $4.3900. Upon request by the Commission Staff, the Issuer or Security Holder, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

        Reporting Owners

        Reporting Owner Name / Address Relationships
        Director 10% Owner Officer Other
        SUNNYVALE, CA 94089

        President & CEO


        By: Oria De La Cerda For: Joshua H Levine 2/13/2013
        ** Signature of Reporting Person Date

5.485+0.005(+0.09%)2:55 PMEDT